Carotid artery dissection is a recognised cause of acute ischemic stroke. When the stroke is attributable to cervical artery dissection, selecting the appropriate acute treatment requires evaluating standard eligibility criteria alongside the dissection diagnosis.
In patients with acute ischemic stroke attributable to cervical artery dissection, acute treatment strategies such as thrombolysis and mechanical thrombectomy are reasonable in otherwise eligible patients.
Intravenous thrombolysis is among the acute interventions considered for eligible patients in this setting.
In patients with acute ischemic stroke attributable to cervical artery dissection, acute treatment strategies such as thrombolysis and mechanical thrombectomy are reasonable in otherwise eligible patients.
Intravenous thrombolysis (IVT), with either alteplase or tenecteplase, is a highly efficacious acute ischemic stroke treatment and leads to improved functional outcome.
In the absence of data suggesting safety concerns and given the proven efficacy of IVT in otherwise eligible patients with acute ischemic stroke, it is reasonable to consider IVT for patients with acute ischemic stroke with cervical artery dissection if they meet other standard criteria, as recommended by current guidelines.
View source ↗